๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Trypsin In poliovaccine manufacture

โœ Scribed by Leonard Hayflick

Book ID
118555498
Publisher
The Lancet
Year
1994
Tongue
English
Weight
166 KB
Volume
343
Category
Article
ISSN
0140-6736

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

Retroviruses and poliovaccines
Retroviruses and poliovaccines
โœ A.J. Garrett; A. Dunham; D.J. Wood ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› The Lancet ๐ŸŒ English โš– 342 KB
HIV contamination of poliovaccines
HIV contamination of poliovaccines
โœ RaphaelB. Stricker; BlaineF. Elswood; A.J. Garrett; SubhashC. Arya ๐Ÿ“‚ Article ๐Ÿ“… 1994 ๐Ÿ› The Lancet ๐ŸŒ English โš– 335 KB
Chitosan as an adjuvant for poliovaccine
Chitosan as an adjuvant for poliovaccine
โœ Y. Ghendon; S. Markushin; I. Akopova; I. Koptiaeva; G. Krivtsov ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 74 KB

## Abstract The use of inactivated poliomyelitis vaccine is very important for eradicating poliomyelitis. However, this vaccine is not available readily in underdeveloped countries due to the high cost. Adjuvants can improve the immunogenicity of a vaccine and reduce the antigen dose required for v